The maximum residue limit (MRL) is the highest concentration of residue accepted by the European Union (EU) in a food product obtained from an animal treated with a veterinary medicine.
EMA's Committee for Veterinary Medicinal Products (CVMP) classifies the residues and establishes MRLs based on scientific risk assessments with defined criteria.
The CVMP evaluates the safety of its pharmacologically active substances and their residues. It also recommends MRLs before a veterinary medicine intended for food-producing animals is authorised in the EU.
This evaluation is based on human dietary exposure assessments.
In addition, the CVMP is responsible for establishing MRLs for pharmacologically active substances in biocidal products used to kills or control germs or pests affecting animals.
While the same principles and guidelines apply to establishing MRLs for pharmacologically active substances in medicines and biocides, EMA has published additional guidance on the risk characterisation and assessment of MRLs for biocides.
In line with Regulation (EC) No 470/2009, the following substances may not require a full MRL assessment:
For more information, see:
As of 19 June 2018, Commission Regulation (EU) 2018/782 describes the methodology to be used in the scientific risk assessment and establishment of risk management recommendations relevant to MRL applications.
These rules replace previous guidance on MRLs, as outlined in volume 8 of 'the rules governing medicinal products in the European Union'.
As of June 2017, Commission Regulation (EU) 2017/880 sets out the principles and minimum criteria for the extrapolation of an MRL to either another foodstuff from the same species or to the same foodstuff from another species.
When finalising an MRL evaluation, the CVMP routinely considers if its conclusions can be extrapolated to additional species and foodstuffs, regardless of whether the applicant has specifically requested this. This aims to increase the availability of veterinary medicines.
The CVMP uses the same criteria when evaluating extension applications.
For more information, see:
EMA sends the CVMP opinion on the MRL application to the European Commission. It then confirms the classification of the substance by including it in the annex to Commission Regulation (EU) No 37/2010.
Allowed substances which may be used in veterinary medicines for food-producing species or biocidal products for use in animal husbandry are listed in table 1 of the annex.
The following information is included:
Prohibited substances which are considered to represent a hazard to the health of the consumer at any level are included in table 2 of the annex.
These substances must not be used in veterinary medicines for food-producing animals or in biocidal products for use in animal husbandry.
For more information, see:
An update log is available to show the date and summary of changes to this webpage. It does not include updates to linked documents or minor edits like typos or broken link fixes.
The tracking of updates begins in April 2026.
8 April 2026
Page first published. Content transferred from the Maximum residue limits (MRL) page.